Clinical Takeaway Randomized controlled trial evidence for cannabinoids as a primary treatment for mental health or substance use disorders remains limited and inconclusive. Current data do not firmly establish efficacy or a...
Endocannabinoid System & Athlete Mental Health Research
Clinical Takeaway Retired professional athletes from high contact team sports such as football, rugby, and ice hockey show elevated rates of depression, anxiety, and cognitive concerns compared to the general population. Key...
`Cannabidiol for Fibromyalgia: Clinical Trial Evidence`
Clinical Takeaway In this randomized, double-blind, placebo-controlled trial, CBD did not demonstrate superiority over placebo in reducing fibromyalgia pain. These findings highlight the current gap between widespread patient use of CBD for...
Cannabinoid Clinical Trials: EEG Sleep Insomnia RCT
Clinical Takeaway In this small pilot trial, a single oral dose of 10 mg THC combined with 200 mg CBD reduced total sleep time in adults with diagnosed insomnia disorder, suggesting that...
Topical Cannabis for AIMSS: Medical Cannabis Evidence-Based Care
Clinical Takeaway Topical cannabis balms were tested in a randomized open-label trial to evaluate their safety and feasibility for managing joint pain and stiffness caused by aromatase inhibitor therapy in breast cancer...
Medical Cannabis RCT for Endometriosis Pain Research
Clinical Takeaway Medicinal cannabis products, including inhaled THC flower and oral oil formulations, were tested against placebo in a three-armed randomized controlled trial to evaluate feasibility and safety for endometriosis pain management...
Endocannabinoid System Research: Cannabis for Endometriosis
Clinical Takeaway Medicinal cannabis is widely self-reported by people with endometriosis for symptom relief, but rigorous clinical evidence has been lacking. This Australian feasibility trial tested inhaled cannabis (16% THC via vaporization)...
Cannabinoid Clinical Trials for Anxiety and Tourette Syndrome
Clinical Takeaway Cannabinoid formulations, particularly CBD-containing products, show measurable reductions in anxiety symptoms across multiple study designs, though effect sizes and optimal dosing vary considerably by condition and formulation. Evidence for Tourette...
Endocannabinoid System & CBD for Autism: RCT Evidence
Clinical Takeaway In a small randomized crossover trial, autistic children aged 5 to 12 received weight-based oral CBD oil at 10 mg/kg/day for 12 weeks. The study examined outcomes including social relating,...
Cannabinoids Show Promise for Chronic Pain, But Evidence Remains Thin
While smaller trials and systematic reviews indicate therapeutic potential, the quality of evidence is often low due to limited sample sizes, short study durations, and methodological inconsistencies. Large-scale, randomized controlled trials with long-term follow-up are urgently needed.